SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-24-064358
Filing Date
2024-05-22
Accepted
2024-05-22 18:18:00
Documents
3
Group Members
ADIUMENTUM CAPITAL FUND I GP LLCGREGORY A. CIONGOLI

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2415124d1_sc13d.htm SC 13D 58427
2 EXHIBIT 99.1 tm2415124d1_ex99-1.htm EX-99.1 6376
3 EXHIBIT 99.2 tm2415124d1_ex99-2.htm EX-99.2 80419
  Complete submission text file 0001104659-24-064358.txt   147000
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88393 | Film No.: 24974696
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 30 GREYLOCK ROAD WELLESLEY MA 02481
Business Address 30 GREYLOCK ROAD WELLESLEY MA 02481 781-235-7974
Adiumentum Capital Fund I LP (Filed by) CIK: 0002023734 (see all company filings)

IRS No.: 992041819 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D